Article Details
Retrieved on: 2021-09-21 14:48:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Like Praise, the Zephyrus studies focus on patients not currently receiving the approved IPF drugs, Roche's Esbriet and Boehringer's Ofev.
Article found on: www.evaluate.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here